Sunday, August 9, 2009


At long last, a competitor to the ever-long-lasting monopolistic Botox has FDA approval.

The company that will distribute Dysport (the new kid on the block) is Medicis, the same people who distribute Restylane. Their initial studies involved 2900 patients nationwide.

Dysport has been used in the United Kingdom since 1991 with an outstanding track record. Yet, to get approval here in the US, many more millions of dollars needed to be spent so that we could have a “safer drug” and certainly a more expensive drug.
Somehow, I believe that 17 years of safe use in the United Kingdom, which included tens of thousands of patients, would be sufficient enough to allow the FDA to go ahead and approve this drug sooner.

How is Dysport different than Botox?

There have not been to date any cross comparison studies between Dysport and Botox. What has come out of the study so far is that Dysport works FASTER and some feel the effects last LONGER i.e. 5 to 6 months versus 4 months for Botox. We are currently in talks with the representatives from Medicis to find out the how’s, why’s and wherefore’s of Dysport.

Keep tuned for more to come. And check in regularly at for updates about all things plastic surgery. Thank you.


Post a Comment

Subscribe to Post Comments [Atom]

Links to this post:

Create a Link

<< Home